SCHEMBL7965727

SCHEMBL7965727

N#Cc1c(C(N)=O)c2n(c1-c1cccnc1)CCC=C2

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 4/20 0.38
MKNK2 Q9HBH9 4/20 0.38
CYP11B2 P19099 5/20 0.37
CSNK1D P48730 1/20 0.37
CSNK1E P49674 1/20 0.37
KDM4E B2RXH2 5/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37
IKBKB O14920 1/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
HTT P42858 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TSHR P16473 1/20 0.36
SCN9A Q15858 2/20 0.36
DYRK1A Q13627 1/20 0.35
CYP11B1 P15538 2/20 0.35
TDP1 Q9NUW8 1/20 0.34
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8329319 0.90 CYP11B2 (0.38) MKNK1MKNK2CYP11B2KDM4EGLA
SCHEMBL7961877 0.89 CYP11B2 (0.40) CYP11B2KDM4EGLAGAAADORA1
SCHEMBL7964071 0.86 CYP11B2 (0.39) CYP11B2ADORA2AADORA1CYP11B1
SCHEMBL7965530 0.84 MKNK1 (0.40) MKNK1MKNK2CYP11B2CSNK1DCSNK1E
SCHEMBL2158254 0.84 MKNK1 (0.43) MKNK1MKNK2CYP11B2CSNK1DCSNK1E
SCHEMBL7952723 0.84 CYP11B2 (0.43) CYP11B2KDM4EGLAGAAIKBKB
SCHEMBL7962850 0.82 MKNK1 (0.41) MKNK1MKNK2CYP11B2CSNK1DCSNK1E
SCHEMBL7963174 0.82 MKNK1 (0.37) MKNK1MKNK2CYP11B2CSNK1DCSNK1E
SCHEMBL7963714 0.80 CYP11B2 (0.34) CYP11B2KDM4ECYP11B1
SCHEMBL2158233 0.78 CYP11B2 (0.42) CYP11B2KDM4EGLAGAAIKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207675-B1 FOR PROPHYLAXIS AND THERAPY OF DISEASES IN WHICH ARE INVOLVED VIRUSES OF THE HERPES FAMILY AND/OR CYTOKINES IN PARTICULAR TUMOR NERCOSIS FACTOR-ALPHA RHONE-POULENC RORER S.A. (FR) 2001-03-27 US claimed
US-6207675-B1 FOR PROPHYLAXIS AND THERAPY OF DISEASES IN WHICH ARE INVOLVED VIRUSES OF THE HERPES FAMILY AND/OR CYTOKINES IN PARTICULAR TUMOR NERCOSIS FACTOR-ALPHA RHONE-POULENC RORER S.A. (FR) 2001-03-27 US disclosed
EP-0946555-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Aventis Pharma S.A. (FR) 1999-10-06 EP disclosed
WO-1998025925-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1998-06-18 WO disclosed